Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ose Immunotherapeutics

Clinical trials sponsored by Ose Immunotherapeutics, explained in plain language.

OSE Immunotherapeutics OSE EURONEXT PARIS

Biotech developing immunotherapies for cancer and autoimmune diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Completed 1

New antibody aims to calm ulcerative colitis when other treatments fail

Disease control Completed

This phase 2 trial tests whether OSE-127, an antibody that blocks a key immune signal, can reduce disease activity in people with moderate to severe ulcerative colitis who have not responded to or cannot tolerate previous treatments. Participants are randomly assigned to receive …

Phase: PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC